Key result
In a retrospective review of 12 cases of synovial sarcoma, 6 patients died during an average follow-up of 18 months, highlighting the poor prognosis of this rare malignancy.
Observational (n=12)
No
Answers are grounded in this paper and cite their sources.
Synovial sarcoma is a rare malignancy affecting young adults with a poor prognosis and diverse histopathology.
BACKGROUND: Synovial sarcoma is a rare malignant soft tissue tumor characterized by a poor outcome. We report herein our experience concerning synovial sarcoma and review its diagnosis, histology, treatment and prognosis. METHODS: This is a retrospective review, from 1990 to 2007, of cases of synovial sarcoma diagnosed at the Department of Pathology, Farhat Hached hospital, Sousse, Tunisia. The clinical, radiological and pathological features as well as treatment modalities and patient's outcome were recorded. RESULTS: From 1990 to 2007, 12 cases of synovial sarcoma have been diagnosed in our department. Patients' mean age at the time of diagnosis was 21 years. There was no sex predominance and the lower extremity was the most commonly involved. A painful tumefaction was the most common presenting symptom. The duration of symptoms ranged from 6 months to 6 years. Malignancy was suspected on radiological findings in only 2 cases. Ten patients underwent surgery, in association with adjuvant chemotherapy in 4 cases, one of whom underwent post-operative radiotherapy. Histological subtypes included monophasic synovial sarcoma in 8 cases, biphasic synovial sarcoma in 3 cases and poorly differentiated synovial sarcoma in one case. At the time of analysis, 6 patients were dead with an average follow-up of 18 months. CONCLUSIONS: Synovial sarcoma is a rare malignancy with a propensity for young adults and a poor prognosis. Its symptomatology is non-specific and it is characterized by histopathological diversity. Diagnosis can be suggested by radiology and definitive diagnosis is achieved after pathological analysis.
No takes yet. Share an insight, caveat, or question.
Soumaya Ben Abdelkrim (2010) conducted an observational in Synovial sarcoma (n=12). Synovial sarcoma was evaluated on Mortality. In a retrospective review of 12 cases of synovial sarcoma, 6 patients died during an average follow-up of 18 months, highlighting the poor prognosis of this rare malignancy.
Synapse has enriched 10 related papers. Consider them for comparative context: